Innate sensing of microbial products promotes wound-induced skin cancer
- Esther Hoste,
- Esther N. Arwert,
- Rohit Lal,
- Andrew P. South,
- ,
- Dedee F. Murrell
- King's College London,
- Cancer Research UK,
- Guy's and St Thomas' NHS Foundation Trust,
- University of Dundee,
- Thomas Jefferson University,
- University of New South Wales (UNSW) Australia
Sustainable Development Goals
- SDG 3 Good Health and Well
Publication metrics
Metrics
Abstract
The association between tissue damage, chronic inflammation and cancer is well known. However, the underlying mechanisms are unclear. Here we characterize a mouse model in which constitutive epidermal extracellular-signal-regulated kinase-MAP-kinase signalling results in epidermal inflammation, and skin wounding induces tumours. We show that tumour incidence correlates with wound size and inflammatory infiltrate. Ablation of tumour necrosis factor receptor (TNFR)-1/-2, Myeloid Differentiation primary response gene 88 or Toll-like receptor (TLR)-5, the bacterial flagellin receptor, but not other innate immune sensors, in radiosensitive leukocytes protects against tumour formation. Antibiotic treatment inhibits, whereas injection of flagellin induces, tumours in a TLR-5-dependent manner. TLR-5 is also involved in chemical-induced skin carcinogenesis in wild-type mice. Leukocytic TLR-5 signalling mediates upregulation of the alarmin HMGB1 (High Mobility Group Box 1) in woundinduced papillomas. HMGB1 is elevated in tumours of patients with Recessive Dystrophic Epidermolysis Bullosa, a disease characterized by chronic skin damage. We conclude that in our experimental model the combination of bacteria, chronic inflammation and wounding cooperate to trigger skin cancer.
Publication Information
Output type
Original language
EnglishArticle number
5932Pages from-to (Number of pages)
Pages 5932Journal (Volume, Issue Number)
Nature Communications (Volume 6)Publication milestones
- Published - 09/01/2015
Publication status
ISSN
2041-1723Publication IDs
- Scopus: 84923506581
- PubMed: 25575023
